Fabric Genomics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Fabric Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012877
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fabric Genomics Inc (Fabric), formerly Omicia Inc is a healthcare solutions provider that offers genome analysis services. The company provides solutions for researchers and clinicians to analyze genomes and disease-causing variants and genes. Its products include opal software and standalone software. Fabric’s opal software offers opal clinical, opal research, opal in silico panels, and opal clinical trials. Omicia’s opal clinical software interprets and reports platform for clinical testing on targeted gene panels, exomes and whole genomes. The company’s VAAST is a disease gene finder and variant scoring algorithm used in academic and clinical institutions. It serves commercial clinical laboratories, country sequencing programs, hospital core labs, and research institutions. Omicia is headquartered in Oakland, California, the US.

Fabric Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fabric Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fabric Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fabric Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fabric Genomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Fabric Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fabric Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Omicia Raises USD23 Million in Series B Financing Round 10
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 11
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 12
Spiral Genetics Raises USD0.2 Million in Venture Financing 13
Omicia Raises US$7 Million In Series A Financing Round 14
Spiral Genetics Raises US$3 Million In Series A Financing 15
Spiral Genetics Raises USD0.1 Million in Venture Financing 16
Partnerships 17
Edico Genome Enters Into Partnership With Fabric Genomics 17
Fabric Genomics and TOMA Biosciences Enter into Partnership 18
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 19
Acquisition 20
Omicia Acquires Spiral Genetics 20
Fabric Genomics Inc – Key Competitors 21
Fabric Genomics Inc – Key Employees 22
Fabric Genomics Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Mar 03, 2016: Omicia Announces Appointment of Matt Tindall as Chief Executive Officer 24
Legal and Regulatory 25
Mar 21, 2017: Omicia Rebrands as Fabric Genomics; Launches New End-to-End Computational Genomics Platform 25
Product News 26
Jan 10, 2017: Omicia Joins Cancer Moonshot’s Blood Profiling Atlas to Advance Circulating Tumor DNA Research 26
Other Significant Developments 27
Oct 19, 2016: Rady Children’s Hospital – San Diego Selects Omicia for NICU/PICU Rapid Whole Genome Sequencing Project 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Fabric Genomics Inc, Medical Equipment, Key Facts 2
Fabric Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Fabric Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fabric Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fabric Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fabric Genomics Inc, Deals By Market, 2011 to YTD 2017 8
Fabric Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Omicia Raises USD23 Million in Series B Financing Round 10
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 11
Spiral Genetics Raises Additional USD0.05 Million in Venture Financing 12
Spiral Genetics Raises USD0.2 Million in Venture Financing 13
Omicia Raises US$7 Million In Series A Financing Round 14
Spiral Genetics Raises US$3 Million In Series A Financing 15
Spiral Genetics Raises USD0.1 Million in Venture Financing 16
Edico Genome Enters Into Partnership With Fabric Genomics 17
Fabric Genomics and TOMA Biosciences Enter into Partnership 18
Real Time Genomics Enters Into Technology Integration Agreement With Omicia 19
Omicia Acquires Spiral Genetics 20
Fabric Genomics Inc, Key Competitors 21
Fabric Genomics Inc, Key Employees 22
Fabric Genomics Inc, Subsidiaries 23

★海外企業調査レポート[Fabric Genomics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析
    F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Bank of East Asia, Limited:企業の戦略・SWOT・財務情報
    The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Lophius Biosciences GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modula …
  • Blue Star Ltd (BLUESTARCO):企業の財務・戦略的SWOT分析
    Summary Blue Star Ltd (BSL) is an air conditioning and commercial refrigeration company that manufactures cooling products. The company’s products include room air conditioners, air purifiers, water purifiers, air coolers, water coolers, cold storages and specialty products. It also offers deep free …
  • Teachers Insurance and Annuity Association of America (TIAA):企業の戦略・SWOT・財務情報
    Teachers Insurance and Annuity Association of America (TIAA) - Strategy, SWOT and Corporate Finance Report Summary Teachers Insurance and Annuity Association of America (TIAA) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers …
  • Banco Santander-Chile:企業の戦略・SWOT・財務分析
    Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report Summary Banco Santander-Chile - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Trina Solar Ltd:電力:M&Aディール及び事業提携情報
    Summary Trina Solar Ltd (Trina Solar) is a vertically-integrated solar power products manufacturer. The company manufactures a wide variety of PV modules, both monocrystalline and multicrystalline; ingots, wafers, cells and solar modules. The company also designs, constructs, sells and operates sola …
  • Beacon Roofing Supply Inc:企業のM&A・事業提携・投資動向
    Beacon Roofing Supply Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beacon Roofing Supply Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Lloyd’s Register Group Ltd:企業の戦略的SWOT分析
    Lloyd's Register Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Prescient Therapeutics Ltd (PTX)-製薬・医療分野:企業M&A・提携分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cancers. The company’s lead drug candidate includes PTX-200, a potent small molecule inhibitor of the A …
  • Karolinska Development AB (KDEV):企業の財務・戦略的SWOT分析
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • TVA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TVA Medical Inc (TVA Medical) is a medical device company that designs and manufactures catheter-based systems. The company offers minimally invasive therapies for treatment of end stage renal disease. It offers everlinq, an endovascular device used for creating an AV fistula for hemodialysi …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務分析
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Edinburgh Molecular Imaging Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • World Fuel Services Corporation:企業のM&A・事業提携・投資動向
    World Fuel Services Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's World Fuel Services Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Sinopec Shanghai Petrochemical Co Ltd (600688):企業の財務・戦略的SWOT分析
    Sinopec Shanghai Petrochemical Co Ltd (600688) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Neiman Marcus Group LTD LLC:戦略・SWOT・企業財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Saudi Telecom Co (7010):企業の財務・戦略的SWOT分析
    Saudi Telecom Co (7010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • FLX Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary FLX Bio Inc (FLX Bio) focuses on the discovery, development and commercialization of novel immuno-oncology agents. The company’s pipeline product, FLX925 is a drug targeting the FLT3 mutations which is found in patients with acute myeloid leukemia (AML). FLX925 simultaneously targets a secon …
  • ConMed Corp (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆